ミシガン州における小細胞肺がんの臨床試験
ミシガン州内の拠点で、小細胞肺がんに関する26件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07155174177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- BAMF Health, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07472517A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Corewell Health William Beaum Hosp, Royal Oak
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/22更新 · NCT07006727A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Barbara Ann Karmanos Cancer Center, Detroit
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/17更新 · NCT07778316A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07325136A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Henry Ford Health Cancer, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- Henry Ford Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/19更新 · NCT06922539A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Henry Ford Health System, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/06更新 · NCT06203210Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Henry Ford Cancer- Detroit, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/28更新 · NCT07339059A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/26更新 · NCT06598306AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/02更新 · NCT07454642MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Karmanos Cancer Center (Wayne State University), Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/29更新 · NCT05903092Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- 他14件
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/30更新 · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/11更新 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Henry Ford Health System, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/01/09更新 · NCT05490472A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
- V.A. Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
被験者募集中第2相
全年齢 · 全性別 · 2025/11/17更新 · NCT05588388A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/23更新 · NCT06805825ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。